Dendrite Appoints Peter Ladell and Peter Tombros to Board of Directors; Appointments to Bring Significant Pharmaceutical Leadership Experience to Dendrite Board

Mr. Ladell served as the Chief Operating Officer of Hoechst MarionRoussel from 1997 until the company's December 1999 merger withRohne-Poulenc Rorer to form Aventis Pharmaceuticals. Mr. Ladellsubsequently served as a member of the Aventis Executive Committeeuntil his retirement in 2001. During his 35 year tenure at HoechstMarion Roussel, and its predecessors, Mr. Ladell served in severalother senior leadership positions, including President and ChiefExecutive Officer, Hoechst Marion Roussel, North America andPresident, Marion Merrell Dow Europe.

Mr. Tombros is the Chairman and Chief Executive Officer ofVivoQuest, Inc., a drug discovery company based in New York. From 1994to 2001, he was President and Chief Executive Officer ofbio-pharmaceutical company Enzon, Inc. Prior to Enzon, Mr. Tombrosspent 25 years with Pfizer, Inc., serving in various leadership roles,including Executive Vice President, Pfizer Pharmaceuticals; SeniorVice President, General Manager, Roerig Division; and Vice President,Marketing, Pfizer Laboratories Division.

"I am extremely pleased to welcome Mr. Ladell and Mr. Tombros toour Board. The Company will benefit from their leadership and deeppharmaceutical industry knowledge," said Dendrite Chairman and ChiefExecutive Officer, John Bailye.

About Dendrite

Founded in 1986, Dendrite International Inc., (NASDAQ: DRTE)provides award-winning sales, marketing, clinical and compliancesolutions and services to global pharmaceutical and other lifesciences companies. With clients in more than 50 countries, includingthe world's top 20 pharmaceutical companies, Dendrite strives to bethe first source for expert promotional and sales effectivenesssolutions. For more information, please visit www.dendrite.com.

Dendrite and the Dendrite logos are trademarks and/or registeredtrademarks of Dendrite International, Inc. All other names aretrademarks and/or registered trademarks of their respective owners.